World Pharma News - Bristol-Myers Squibb to Announce Results for the Third Quarter of 2007 on October 25

Home News Channels Contact Us Search XING Forums Members Login

Conferences & Events 2nd Annual Global Business Intelligence Summit How to Implement Risk Management Principles and Activities Within a Quality Management System One World One Health: Political and Practical Challenges BioQatar Symposium 2008 - Translating Clinical Research into Business Ventures	Research & Development UK's Government and Industry in drug price deal Manhattan Research Releases Report on the Future of Physician Customer Service Portals FDA Warns Public of Extortion Scam by FDA Impersonators Pfizer Launches Global Regenerative Medicine Research Unit
Read more...	Read more...

Welcome

World Pharma News is an ambitious online news service dedicated to the world pharmaceutical industry. Our main goal is to keep our readers informed about the latest worldwide pharmaceutical news, realizations and achievements.

Register now to be in touch with our last developments and achievements or Subscribe to World Pharma News alerts by Email (a free service delivered by FeedBurner).

Non progredi est regredi.

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]

Pharmaceutical RSS News

Start your day with worldwide pharmaceutical

European Commission - Pharmaceuticals
FDA

US Food and Drug Administration

Get all news digests delivered to your inbox, subscribe to World Pharma News Google Group.

Email:

World Pharma News .net / Published News

Our RSS News Channels

Sponsored Ads

Bristol-Myers Squibb to Announce Results for the Third Quarter of 2007 on October 25

Monday, 15 October 2007

Bristol-Myers Squibb Company (NYSE: BMY) will announce results for the third quarter of 2007 on Thursday, October 25. During a conference call on October 25 at 10:30 a.m. (ET), financial information will be reviewed and company executives will address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the call at http://www.bms.com/ir or by dialing 913-981-4911. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 2 p.m. (ET) on October 25 through midnight (ET) on November 7. You may access the replay at http://www.bms.com/ir or by dialing 402-280-9013 (access code 6710942).

About Bristol-Myers Squibb
Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life. For more information, visit www.bms.com.

Bookmark with:

< Prev		Next >

[ Back ]

Sponsored Ads

Product EMEA recommends the suspension of the marketing authorisation of Ionsys (fentanyl hydrochloride) Pfizer withdraws its application to change the marketing authorisation for Viagra Russia Chooses Inactivated Polio Vaccine from Sanofi Pasteur for Primary Immunization of All Infants SEROQUEL XR and SEROQUEL Approved in Europe for New Indications FDA Seizes Contaminated Heparin from a Cincinnati Manufacturer	Clinical Trials Tarceva brings new hope to patients with advanced non-small cell lung cancer Bayer's Xarelto� Shows Encouraging Results in Patients with Acute Coronary Syndrome CRESTOR� is in line with other marketed statins - new data from the JUPITER study Early data show potential for imatinib to treat life-threatening form of pulmonary artery disease Bayer Reports Progress in Clinical Program for Riociguat	Corporate AstraZeneca granted Temporary Restraining Order in PULMICORT RESPULES patent litigation Pfizer and UCB Announce Formation of New Company Cyclofluidic to Accelerate Drug Discovery Process Pfizer Reaches Agreements in Principle to Resolve Litigation Involving Its NSAID Pain Medications European Journalists' Prize 2008 announced by Bayer HealthCare Genzyme Recognized by Scientists as a Top Employer	Financial Genzyme and Osiris Partner to Develop and Commercialize First-in-Class Adult Stem Cell Products GlaxoSmithKline to acquire Genelabs Technologies to increase focus on novel small molecule therapies AstraZeneca PLC Third Quarter and Nine Months Results 2008 Novartis to acquire Nektar Therapeutics pulmonary business unit Roche posts sustained double-digit sales growth for the first nine months of 2008
Read more...	Read more...	Read more...	Read more...

Conferences & Events

Research & Development

Welcome

Pharmaceutical Companies

Sponsored Ads

Pharmaceutical RSS News

World Pharma News .net / Published News

Our RSS News Channels

Sponsored Ads

Most Read - Financial

Sponsored Ads

Product

Clinical Trials

Corporate

Financial